Entera Bio Ltd. (ENTX) stock
ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.00−0.02 (-0.66%)
Close on Nov 17, 2026Market cap $519.43MP/E –Yield –
Entera Bio pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Entera Bio's pe ratio was 3.4× on Jan 31, 2022, against 1.6× a year earlier. Over the last 4 years it ranged from 1.2× to 8.9×, with a median of 2.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jan 31, 2022 | 3.4× | −0.8 |
| 2021 | Dec 31, 2021 | 4.2× | +3.0 |
| 2020 | Dec 31, 2020 | 1.2× | −0.4 |
| 2019 | Dec 31, 2019 | 1.6× | +0.4 |
| 2018 | Dec 31, 2018 | 1.2× | – |
See a number that looks wrong?